Prognostic Significance of CD56 Antigen Expression in Patients with
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2021
2021
Historique:
received:
29
05
2020
revised:
02
02
2021
accepted:
20
03
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
26
5
2021
Statut:
epublish
Résumé
Acute myeloid leukemia (AML) is a heterogeneous group of disorders with distinct characteristics and prognoses. Although cytogenetic changes and gene mutations are associated with AML prognosis, there is a need to identify further factors. CD56 is considered a prognostic factor for AML, which is abnormally expressed in leukemia cells. However, a clear consensus for this surface molecule is lacking, which has prompted us to investigate its prognostic significance. Bone marrow samples of
Identifiants
pubmed: 33928145
doi: 10.1155/2021/1929357
pmc: PMC8049794
doi:
Substances chimiques
CD56 Antigen
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1929357Informations de copyright
Copyright © 2021 Yanni Sun et al.
Déclaration de conflit d'intérêts
The authors have no conflicts of interests.
Références
J Mol Cell Cardiol. 2017 Nov;112:49-57
pubmed: 28870505
Blood. 2018 Jan 25;131(4):387-396
pubmed: 29196412
Transplant Proc. 2016 Jun;48(5):1814-7
pubmed: 27496498
Biomed Pharmacother. 2018 Jan;97:225-232
pubmed: 29091870
Dtsch Med Wochenschr. 2018 Sep;143(18):1297-1303
pubmed: 30199909
BMJ Case Rep. 2018 Jan 12;2018:
pubmed: 29330269
Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):104-8
pubmed: 25679063
Mol Ther. 2016 Sep 29;24(9):1615-26
pubmed: 27401038
Cytometry B Clin Cytom. 2020 Jan;98(1):52-56
pubmed: 31294507
Immunology. 2018 Mar 14;:
pubmed: 29542114
Blood Rev. 2018 Mar;32(2):89-95
pubmed: 29033137
Br J Haematol. 2016 Aug;174(4):600-9
pubmed: 27072379
J Hematol Oncol. 2017 Jul 25;10(1):142
pubmed: 28743264
J Clin Oncol. 2004 Aug 15;22(16):3432-3
pubmed: 15310791
Blood. 2019 Apr 11;133(15):1630-1643
pubmed: 30803991
Cell Rep. 2018 Jan 16;22(3):748-759
pubmed: 29346771
Lancet. 2018 Aug 18;392(10147):593-606
pubmed: 30078459
J Invest Dermatol. 2018 Sep;138(9):2063-2066
pubmed: 29601811
Int J Mol Sci. 2017 Nov 15;18(11):
pubmed: 29140271
Blood. 2013 Oct 31;122(18):3138-48
pubmed: 24030378
MAbs. 2016 May-Jun;8(4):799-810
pubmed: 26910291
Trials. 2018 Sep 5;19(1):476
pubmed: 30185214
Int J Hematol. 2018 May;107(5):513-518
pubmed: 29374826
Blood Rev. 2006 Mar;20(2):71-82
pubmed: 16185796
Ther Adv Hematol. 2019 Jul 10;10:2040620719860645
pubmed: 31321011
Sci Transl Med. 2017 Jan 25;9(374):
pubmed: 28123069
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Leuk Res. 2004 Oct;28(10):1007-11
pubmed: 15289011
Int J Lab Hematol. 2015 Dec;37(6):e157-9
pubmed: 26147745
J Clin Oncol. 2016 Jul 1;34(19):2212-20
pubmed: 27091716
Leukemia. 2018 Aug;32(8):1671-1678
pubmed: 30026570
Clin Cancer Res. 2004 Nov 1;10(21):7252-9
pubmed: 15534099
J Natl Compr Canc Netw. 2017 Jul;15(7):926-957
pubmed: 28687581
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Blood. 2019 May 23;133(21):2305-2319
pubmed: 30814062
J Clin Med. 2019 Aug 20;8(8):
pubmed: 31434267
Blood Cancer J. 2015 Apr 17;5:e304
pubmed: 25885425
Rev Bras Hematol Hemoter. 2011;33(3):202-6
pubmed: 23049296
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Aug;24(4):990-7
pubmed: 27531762
Ann Hematol. 2019 Jun;98(6):1403-1411
pubmed: 30915498